Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

409
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
409
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

903
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
903
Pharmacovigilance01:19

Pharmacovigilance

1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.6K
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

565
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
565
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

471
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
471

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Seasonal variation of reproductive performance, foetal development and progesterone concentrations of sheep in the subtropics.

Reproduction in domestic animals = Zuchthygiene·2008
Same author

Validation of a soccer skill test for use with females.

International journal of sports medicine·2008
Same author

Assessment of the need to coat particle collection cups of the NGI to mitigate droplet bounce when evaluating nebuliser-produced droplets.

Pharmeuropa scientific notes·2008
Same author

Cooling the NGI - an approach to size a nebulised aerosol more accurately.

Pharmeuropa scientific notes·2008
Same author

Multiplex PCR for differential diagnosis of emerging typhoidal pathogens directly from blood samples.

Epidemiology and infection·2008
Same author

Gelrite microgels for sustained oral drug delivery-formulation and evaluation.

Current drug delivery·2008

Related Experiment Video

Updated: Jan 19, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.1K

Cochrane's Linked Data Project: How it Can Advance our Understanding of Surrogate Endpoints.

Chris Mavergames1, Deirdre Beecher1, Lorne A Becker1

  • 1Chris Mavergames, M.Sc., is the Chief Information Offier, Cochrane Informatics and Technology (IT) Services and a member of the Cochrane Central Executive team. Deirdre Beecher, M.Sc., is a Senior Metadata Specialist, Cochrane Informatics and Technology (IT) Services and is a member of the Cochrane Central Executive team. Lorne A. Becker, M.D., is at Cochrane and is an Emeritus Professor in the Department of Family Medicine, SUNY Upstate Medical University, in Syracuse, NY. A. Last works as a Medical Terminology Manager at Cochrane Informatics and Technology (IT) Services and is a member of the Cochrane Central Executive team. A. Ali works at the Cochrane Informatics and Technology (IT) Services and is a member of the Cochrane Central Executive team.

The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics
|September 28, 2019
PubMed
Summary

Cochrane created a linked data system to improve access to health evidence. This makes research on biomarkers and surrogate endpoints more discoverable for better health decisions.

More Related Videos

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.2K
In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.2K

Related Experiment Videos

Last Updated: Jan 19, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.1K
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.2K
In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.2K

Area of Science:

  • Health Sciences
  • Biomedical Informatics
  • Data Science

Background:

  • Cochrane possesses extensive repositories of health evidence.
  • Effective evidence-based decision-making relies on accessible and well-organized data.
  • Discoverability of research data is crucial for scientific advancement.

Purpose of the Study:

  • To develop a linked data infrastructure for Cochrane's repositories.
  • To enhance the discoverability of health evidence and associated data.
  • To support evidence-based health decision-making and research on biomarkers and surrogate endpoints.

Main Methods:

  • Implementation of a linked data infrastructure.
  • Annotation of resources within Cochrane's repositories.
  • Development of systems for data integration and accessibility.

Main Results:

  • Improved discoverability of evidence and data from Cochrane's repositories.
  • Creation of annotated resources facilitating deeper understanding.
  • Enhanced potential for studying biomarkers and surrogate endpoints.

Conclusions:

  • The linked data infrastructure significantly enhances the accessibility and utility of Cochrane's evidence base.
  • This initiative supports advancements in the study of biomarkers and surrogate endpoints.
  • The project facilitates more informed evidence-based health decision-making.